Leite John's Form 4 filing
Veracyte, Inc. (VCYT) · filed Jun 4, 2026
- Accession no.
- 0001991536-26-000009
- Filed
- Jun 4, 2026
- Trade date
- Jun 2-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $699.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leite JohnCIK 0001991536 | Officer (Global Chief Commercial Off) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock | FTax withholdingDisposed | −4,059 | $47.80 | −$194,020.2 | 146,280 | Direct | |
| Jun 4, 2026 | Common Stock | SSaleDisposed | −13,975 | $50.07F3 | −$699,728.25 | 132,305 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.